Home › Acute Myeloid Leukemia › New York › Greenburgh
Acute Myeloid Leukemia clinical trials in Greenburgh, NY
18 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Greenburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi away
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
RecruitingPhase 1
- New York Medical College /ID# 275597, Valhalla · 5 mi away
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
RecruitingPhase 1
- Memorial Sloan Kettering Bergen, Montvale · 9 mi away
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi away
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi away
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi away
A Study of CRD3874-SI in People With Leukemia
RecruitingPhase 1
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi away
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi away
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RecruitingPhase 3
- New York Medical College, Valhalla · 5 mi away
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- New York Medical College, Valhalla · 5 mi away
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
RecruitingPhase 2
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi away
A Study of Revumenib and Mezigdomide in People With Leukemia
RecruitingPhase 1/2
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi away
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
RecruitingPhase 1
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi away
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
RecruitingPhase 1
- Memorial Sloan Kettering Bergen, Montvale · 9 mi away
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
RecruitingPhase 1
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi away
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
RecruitingPhase 1
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi away
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
RecruitingPhase 2
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi away
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
RecruitingPhase 2
- White Plains Hospital, White Plains · 4 mi away
About Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.
More about Acute Myeloid Leukemia on MedlinePlus
Acute Myeloid Leukemia trials in other cities
- Houston, TX85 studies
- New York City, NY51 studies
- Boston, MA44 studies
- Seattle, WA41 studies
- Baldwin Park, CA40 studies
- Columbus, OH35 studies
- Philadelphia, PA34 studies
- Durham, NC33 studies
- Atlanta, GA31 studies
- Tampa, FL29 studies
- Chicago, IL26 studies
- Portland, OR25 studies
Other studies in Greenburgh
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer28 studies
- Prostate Cancer17 studies
- Cancer (all types)17 studies
- Lung Cancer17 studies
- Multiple Myeloma13 studies
- Colorectal Cancer11 studies
- Metastatic Cancer11 studies
- Endometrial Cancer11 studies
- Bladder Cancer10 studies
- Lymphoma9 studies
- Head and Neck Squamous Cell Carcinoma9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.